Details
| Originalsprache | Englisch |
|---|---|
| Titel des Sammelwerks | Lifetime Nutritional Influences on Cognition, Behaviour and Psychiatric Illness |
| Herausgeber/-innen | D. Benton |
| Erscheinungsort | Cambridge |
| Herausgeber (Verlag) | Elsevier Ltd. |
| Seiten | 32-78 |
| Seitenumfang | 47 |
| ISBN (Print) | 9781845697525 |
| Publikationsstatus | Veröffentlicht - Juli 2011 |
Abstract
Long-chain polyunsaturated fatty acids (LC-PUFAs), particularly docosahexaenoic acid (DHA) and arachidonic acid (AA), play a central role in infancy for normal brain development. They are involved in numerous neuronal processes, ranging from effects on membrane fluidity, signal transduction, neurotransmission to gene expression regulation. Since observational studies have indicated that the visual and cognitive performance of breastfed infants is advantaged compared to formula-fed infants, numerous randomized controlled studies have studied whether infant formulas supplemented with DHA or both DHA and AA would enhance visual and cognitive development of both term and preterm infants. This chapter gives an overview on the significance of LC-PUFAs in neurodevelopment, with a special focus on the findings from these studies.
Zitieren
- Standard
- Harvard
- Apa
- Vancouver
- BibTex
- RIS
Lifetime Nutritional Influences on Cognition, Behaviour and Psychiatric Illness. Hrsg. / D. Benton. Cambridge: Elsevier Ltd., 2011. S. 32-78.
Publikation: Beitrag in Buch/Bericht/Sammelwerk/Konferenzband › Beitrag in Buch/Sammelwerk › Forschung › Peer-Review
}
TY - CHAP
T1 - Influence of long-chain polyunsaturated fatty acids (LC-PUFAs) on cognitive and visual development
AU - Schuchardt, J. P.
AU - Hahn, A.
PY - 2011/7
Y1 - 2011/7
N2 - Long-chain polyunsaturated fatty acids (LC-PUFAs), particularly docosahexaenoic acid (DHA) and arachidonic acid (AA), play a central role in infancy for normal brain development. They are involved in numerous neuronal processes, ranging from effects on membrane fluidity, signal transduction, neurotransmission to gene expression regulation. Since observational studies have indicated that the visual and cognitive performance of breastfed infants is advantaged compared to formula-fed infants, numerous randomized controlled studies have studied whether infant formulas supplemented with DHA or both DHA and AA would enhance visual and cognitive development of both term and preterm infants. This chapter gives an overview on the significance of LC-PUFAs in neurodevelopment, with a special focus on the findings from these studies.
AB - Long-chain polyunsaturated fatty acids (LC-PUFAs), particularly docosahexaenoic acid (DHA) and arachidonic acid (AA), play a central role in infancy for normal brain development. They are involved in numerous neuronal processes, ranging from effects on membrane fluidity, signal transduction, neurotransmission to gene expression regulation. Since observational studies have indicated that the visual and cognitive performance of breastfed infants is advantaged compared to formula-fed infants, numerous randomized controlled studies have studied whether infant formulas supplemented with DHA or both DHA and AA would enhance visual and cognitive development of both term and preterm infants. This chapter gives an overview on the significance of LC-PUFAs in neurodevelopment, with a special focus on the findings from these studies.
KW - AA
KW - Arachidonic acid
KW - Brain growth
KW - Cognitive development
KW - DHA
KW - Dietary requirements
KW - Docosahexaenoic acid
KW - Infant formula
KW - Infant nutrition
KW - LC-PUFA
KW - Long-chain polyunsaturated fatty acids
KW - Maternal nutrition
KW - Omega-3 fatty acids
KW - Perinatal development
KW - Pregnancy
KW - Supplementation
KW - Visual development
UR - http://www.scopus.com/inward/record.url?scp=84902404518&partnerID=8YFLogxK
U2 - 10.1533/9780857092922.1.32
DO - 10.1533/9780857092922.1.32
M3 - Contribution to book/anthology
AN - SCOPUS:84902404518
SN - 9781845697525
SP - 32
EP - 78
BT - Lifetime Nutritional Influences on Cognition, Behaviour and Psychiatric Illness
A2 - Benton, D.
PB - Elsevier Ltd.
CY - Cambridge
ER -